Performance of the VitaPCR rapid molecular test for SARS-CoV-2 screening at hospital admission
Description
CONCLUSION: High-sensitivity testing is needed to limit nosocomial spread and identify asymptomatic COVID-19 patients. However, time advantage of the VitaPCR must be weighed against its significantly lower sensitivity, especially when used in high